These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25754418)

  • 21. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.
    Lozano M; Knutson F; Tardivel R; Cid J; Maymó RM; Löf H; Roddie H; Pelly J; Docherty A; Sherman C; Lin L; Propst M; Corash L; Prowse C
    Br J Haematol; 2011 May; 153(3):393-401. PubMed ID: 21418180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
    Kaiser-Guignard J; Canellini G; Lion N; Abonnenc M; Osselaer JC; Tissot JD
    Blood Rev; 2014 Nov; 28(6):235-41. PubMed ID: 25192602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human platelet concentrates treated with microbicidal 405 nm light retain hemostasis activity.
    Jackson JW; Kaldhone PR; Parunov LA; Stewart CF; Anderson JG; MacGregor SJ; Maclean M; Atreya CD
    J Photochem Photobiol B; 2024 Jun; 255():112922. PubMed ID: 38677260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial.
    Brixner V; Bug G; Pohler P; Krämer D; Metzner B; Voss A; Casper J; Ritter U; Klein S; Alakel N; Peceny R; Derigs HG; Stegelmann F; Wolf M; Schrezenmeier H; Thiele T; Seifried E; Kapels HH; Döscher A; Petershofen EK; Müller TH; Seltsam A
    Haematologica; 2021 Apr; 106(4):1086-1096. PubMed ID: 33538149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy.
    Blundell EL; Pamphilon DH; Fraser ID; Menitove JE; Greenwalt TJ; Snyder EL; Repucci AJ; Hedberg SL; Anderson JK; Buchholz DH; Kagen LR; Aster RH
    Transfusion; 1996 Apr; 36(4):296-302. PubMed ID: 8623127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow path system of ultraviolet C irradiation from xenon flash to reduce bacteria survival in platelet products containing a platelet additive solution.
    Abe H; Endo K; Shiba M; Niibe Y; Miyata S; Satake M
    Transfusion; 2020 May; 60(5):1050-1059. PubMed ID: 32187695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres.
    van der Meer PF; Couture C; Hervig T; Kruit G; Devine DV; de Korte D; Kerkhoffs JL
    Vox Sang; 2017 Jan; 112(1):9-17. PubMed ID: 28001293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets.
    Castro E; González LM; Rubio JM; Ramiro R; Gironés N; Montero E
    Transfusion; 2014 Sep; 54(9):2207-16. PubMed ID: 24666393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of SARS-CoV-2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light.
    Hobson-Peters J; Amarilla AA; Rustanti L; Marks DC; Roulis E; Khromykh AA; Modhiran N; Watterson D; Reichenberg S; Tolksdorf F; Sumian C; Seltsam A; Gravemann U; Faddy HM
    Transfusion; 2023 Feb; 63(2):288-293. PubMed ID: 36573801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of platelet concentrates and plasma with riboflavin and UV light: Impact in bacterial reduction.
    Bello-López JM; Delgado-Balbuena L; Rojas-Huidobro D; Rojo-Medina J
    Transfus Clin Biol; 2018 Sep; 25(3):197-203. PubMed ID: 29656962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of refrigerated storage of UVC pathogen inactivated platelet concentrates on in vitro platelet quality parameters.
    Johnson L; Cameron M; Waters L; Padula MP; Marks DC
    Vox Sang; 2019 Jan; 114(1):47-56. PubMed ID: 30499111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of ultraviolet light in the preparation of platelet concentrates.
    Pamphilon DH; Corbin SA; Saunders J; Tandy NP
    Transfusion; 1989 Jun; 29(5):379-83. PubMed ID: 2525287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Feasibility study for Intercept platelets].
    Bardiaux L; Vauzou S; Olivier B; Mathieu-Daude D; Durand E; Dite C; Roubinet F
    Transfus Clin Biol; 2016 Nov; 23(4):212-216. PubMed ID: 27644172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control of riboflavin-treated platelet concentrates using Mirasol® PRT system: Polish experience.
    Lachert E; Kubis J; Antoniewicz-Papis J; Rosiek A; Woźniak J; Piotrowski D; Przybylska Z; Mikołowska A; Marschner S; Łętowska M
    Adv Clin Exp Med; 2018 Jun; 27(6):765-772. PubMed ID: 29877637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.
    Mohr H; Gravemann U; Bayer A; Müller TH
    Transfusion; 2009 Sep; 49(9):1956-63. PubMed ID: 19497057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo.
    Margolis-Nunno H; Bardossy L; Robinson R; Ben-Hur E; Horowitz B; Blajchman MA
    Transfusion; 1997 Sep; 37(9):889-95. PubMed ID: 9308633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.